Dr Sarah Redvers, a safeguarding GP in England, has brought a constructive dismissal claim against NHS Sussex after she said she was bullied and harassed out of her job for raising patient safety concerns about gender care practices.

Redvers raised concerns starting in July 2020 after other doctors contacted her about prescribing practices at WellBN, a Brighton clinic. She said Dr Sam Hall, who worked there, was recommending puberty-blocking drugs and cross-sex hormones to young people he had not properly assessed. She passed these concerns through official NHS whistleblower channels.

NHS investigations into her complaints twice concluded there was no cause for concern with Hall's practice. During these investigations, Redvers said she was accused of transphobia and warned by an investigator that there was a "general worry" about allegations of transphobia. She described the subsequent investigation into her own conduct as a "brutal" four-hour interrogation. She said the focus on investigating her meant patient safety issues were sidelined.

In 2021, prompted by concerns about care for a 15-year-old, Redvers referred Hall to the General Medical Council. Hall then emailed NHS Sussex CEO Adam Doyle directly, saying Redvers was victimising him and disrupting his career. The tribunal heard Doyle had previously had mentoring meetings with Hall, though he initially denied knowing him before this complaint.

In June 2026, nearly six years after Redvers first raised concerns, a separate NHS safety investigation found that 78 children, some as young as 13, had been potentially harmed. The report stated children at WellBN had been inappropriately prescribed drugs without proper checks. NHS England said it was "totally unacceptable" that young people were put at risk.

NHS Surrey and Sussex acknowledged that "some employment processes should have been handled differently" and apologised to Redvers. Hall is a trans man and qualified GP known as a campaigner for transgender rights who advocates "affirmative care" in gender medicine. Redvers said her concerns were about medical assessment quality and evidence, not about gender identity views.